INTRODUCTION
Snake envenomation is an important public health hazard throughout the world particularly in third world countries. Viper bite is quite common in South East Asia. Several species of snakes of viperidae family produce venoms that have a wide range of activities affecting hemostasis. Snake envenomation is a complex phenomenon manifest as hematological, renal, cardiac and neurological abnormalities. However ischemic manifestations like, acute myocardial or cerebral infarction is quite uncommon.
1,2 Such cases are rarely reported in literature.
CASE REPORT
A twenty one year male admitted in our hospital with history of viper snake bite on dorsum of right hand while he was working in the field. He received total twenty vials (10 vials each, at an interval of 6 hours, intravenously) of lyophilized polyvalent anti-snake venom serum, started within three hours of bite in a local hospital. Later on, he was transferred to IPGME&R as he developed acute renal failure.
On the day of admission, he was drowsy (Glasgow coma scale 11/15); two bite marks were present on the dorsum of right hand with local swelling involving forearm and ecchymoses ( Figure 1 ). Puffiness of face with pedal edema was present. There was no bleeding manifestation, no ptosis, mildly dilated pupils with normal light reaction. Ophthalmoscopy was normal. He passed only 100 ml of urine in last twenty four hours. He was hemodynamically stable with a respiratory rate of 20/min, Mild anemia was present. Apart from drowsiness, neurological examination was unremarkable without any evidence of cranial nerve palsy. Other systems were normal. Investigation revealed, hemoglobin 11 gm%, TLC 10500/cumm, platelet 80000/cumm. Blood urea -196 mg/dl, serum creatinine -9.1 mg/dl, random blood sugar -124 mg/dl. Sodium -137 mmol/dl, Potassium -5.4 mmol/dl, hepatic function was normal and whole blood clotting time was fifteen minutes. Patient was put on hemodialysis. 
DISCUSSION
Neurodeficit following viper bite is not uncommon. Usually it manifests as intracerebral or subarachnoid hemorrhage.
3 Cerebral infarction is rare and there are only few case reports all over world.
Snake venom is a complex fluid. Main components of snake venom are protease, collagenase and phospholipases, which are responsible for local swelling, tissue destruction, vascular damage, alteration of coagulation profile and neurotoxicity. Most of the viper venom exhibit both anticoagulant and coagulant effects. As a pro coagulant it has thrombin like activity, can activate prothrombin even in the absence of calcium ion, activate factor x and v and endothelial cells. 4 Features of viper bite depend on severity of envenomation and bleeding manifestations are commonly encountered in the clinical practice. Thrombotic manifestations are uncommon. Large doses of venom can produce massive intravascular clotting with ischemic sequelae of major organs. 4 In a prospective study in Sri Lanka on 500 victims of D. russelii bites, 9 patients (1.8%) have CT evidence of ischemic strokes involving medium to large vessel territories of the brain. According to this study, pro thrombotic property of the viper venom was the putative mechanism. 5 In another study on 309 snake bite patients, ischemic stroke was present in only one patient. 6 There are several mechanisms by which cerebral infarction can occur in viper bite. 1) Hypotension, which can cause watershed infraction. Hypotension can be due to excessive sweating, vomiting, and increased vascular permeability due to release of vasogenic agents or adrenal hemorrhage. 2) Endothelial injury by direct action of components of viper venom on vessel wall may produce vasculitis and local thrombosis. 3) Hypercoagulability -it can be due to procoagulants in the venom such as arginine, esterase, hydrolase, hyper viscosity due to hypotension, 4) Vascular -hemorrhaging are complement mediated toxic components of viperidae that causes severe vascular spasms followed by vasodilatation, while at capillaries they causes increased vascular permeability, resulting in hemorrhagic infarct. 3, 7 Reports of thrombotic phenomenon following viper bite are small in number.
The details of case reports of post viper bite cerebral infraction are given below in a tabular form. Previously it has been showed that, in Bothrops lanceolatus snake bite, early institution of AVS decreases the rate of thrombotic manifestations. 14 In our patient early administration of AVS failed to prevent thrombotic squeal. The cause may be due to variation in snake species or development of DIC.
Our patient never presented with hypotension and there was no imaging feature of water shed infarction. Hematological investigations were suggestive DIC. Overt thromboembolic manifestation can occur in 10-40% cases of DIC. DIC may trigger different hemoststic and cellular pathways for thrombin and plasmin generation, resulting in clinico-pathological process that favours thrombosis or consumption with bleeding.
More common differentials of stroke in a young patient like, cardio embolisation, cerebral arterio venous malformation, carotid artery dissection, anti-phospholipid antibody syndrome were reasonably excluded in our patient and there was no history of any drug abuse.
Most of the cases of viper bite occur in third world countries. It is believed that complications may be more common than is reported in the literature, which may be due to inefficient reporting system and lack of infrastructure. A physician must consider the rare possibility of cerebral infarction in institution viper bite even after neutralization of toxin by early of AVS.
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